Infectivity of Leishmania mexicana is associated with differential expression of protein kinase C-like triggered during a cell-cell contact

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Alvarez Rueda, Nidia ^a   Biron, Marlène ^a   Le Pape, Patrice ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; CALCIUM ION; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLSERINE; PROTEIN KINASE C; PROTEIN KINASE N;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL COUNT; CELL FREE SYSTEM; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HOST PARASITE INTERACTION; IMMUNOBLOTTING; INTERNALIZATION; LEISHMANIA MEXICANA; LEISHMANIASIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITE VIRULENCE; PROMASTIGOTE; PROTEIN MICROARRAY; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; BIOLOGY; CELL COMMUNICATION; GENE EXPRESSION REGULATION; METABOLISM; PARASITOLOGY; PATHOGENICITY;

LEISHMANIA MEXICANA; LEISHMANIA SP.; MAMMALIA;

ANIMALS; ANTIBODY SPECIFICITY; CELL COMMUNICATION; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LEISHMANIA MEXICANA; LEISHMANIASIS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; PROTEIN ARRAY ANALYSIS; PROTEIN KINASE C;

EID: 70449601737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007581     Document Type: Article

References (56)

1. Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet 366: 1561-1577.
2. Barreto-de-Souza V, Pacheco GJ, Silva AR, Castro-Faria-Neto HC, Bozza PT, et al. (2006) Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis 194: 846-854.
3. Seaman J, Mercer AJ, Sondorp E (1996) The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 25: 862-871.
4. Reithinger R, Mohsen M, Aadil K, Sidiqi M, Erasmus P, et al. (2003) Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis 9: 727-729.
5. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
6. Korzeniewski K, Olszanski R (2004) Leishmaniasis among soldiers of stabilization forces in Iraq. Review article. Int Marit Health 55: 155-163.
7. Croft SL, Coombs GH (2003) Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 19: 502-508.
8. Ouellette M, Borst P (1991) Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania. Res Microbiol 142: 737-746.
9. Croft SL, Barrett MP, Urbina JA (2005) Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 21: 508-512.
10. Le Pape P (2008) Development of new antileishmanial drugs-current knowledge and future prospects. J Enzyme Inhib Med Chem 23: 708-718.
11. Brittingham A, Morrison CJ, McMaster WR, McGwire BS, Chang KP, et al. (1995) Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol 155: 3102-3111.
12. Beverley SM, Turco SJ (1995) Identification of genes mediating lipopho-sphoglycan biosynthesis by functional complementation of Leishmania donovani mutants. Ann Trop Med Parasitol 89 Suppl 1: 11-17.
13. Yao C, Leidal KG, Brittingham A, Tarr DE, Donelson JE, et al. (2002) Biosynthesis of the major surface protease GP63 of Leishmania chagasi. Mol Biochem Parasitol 121: 119-128.
14. McGwire BS, O'Connell WA, Chang KP, Engman DM (2002) Extracellular release of the glycosylphosphatidylinositol (GPI)-linked Leishmania surface metalloprotease, gp63, is independent of GPI phospholipolysis: implications for parasite virulence. J Biol Chem 277: 8802-8809.
15. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, et al. (2005) The genome of the kinetoplastid parasite, Leishmania major. Science 309: 436-442.
16. Myler PJ (2008) Searching the Tritryp genomes for drug targets. Adv Exp Med Biol 625: 133-140.
17. Hanks SK, Hunter T (1995) Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. Faseb J 9: 576-596.
18. Naula C, Parsons M, Mottram JC (2005) Protein kinases as drug targets in trypanosomes and Leishmania. Biochim Biophys Acta 1754: 151-159.
19. Newton AC (1995) Protein kinase C: structure, function, and regulation. J Biol Chem 270: 28495-28498.
20. Jaken S (1996) Protein kinase C isozymes and substrates. Curr Opin Cell Biol 8: 168-173.
21. Roffey J, Rosse C, Linch M, Hibbert A, McDonald NQ, et al. (2009) Protein kinase C intervention: the state of play. Curr Opin Cell Biol 21: 268-279.
22. Parsons M, Worthey EA, Ward PN, Mottram JC (2005) Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMC Genomics 6: 127.
23. Banerjee C, Sarkar D (1990) Partial purification and characterization of a soluble protein kinase from Leishmania donovani promastigotes. J Gen Microbiol 136: 1051-1057.
24. Vannier-Santos MA, Martiny A, Meyer-Fernandes JR, de Souza W (1995) Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase. Eur J Cell Biol 67: 112-119.
25. Vieira LL, Lafuente E, Blum J, Cabantchik ZI (1997) Modulation of the swelling-activated amino acid channel of Leishmania major promastigotes by protein kinases. Mol Biochem Parasitol 90: 449-461.
26. Alvarez N, Robledo S, Velez ID, Robert JM, Le Baut G, et al. (2002) Inhibition of parasite protein kinase C by new antileishmanial imidazolidin-2-one compounds. J Enzyme Inhib Med Chem 17: 443-447.
27. de Almeida-Amaral EE, Caruso-Neves C, Pires VM, Meyer-Fernandes JR (2008) Leishmania amazonensis: characterization of an ouabain-insensitive Na+-ATPase activity. Exp Parasitol 118: 165-171.
28. Babinska A, Hogan MV, Sobocki T, Sobocka MB, Ehrlich YH, et al. (2000) Identification of ecto-PKC on surface of human platelets: role in maintenance of latent fibrinogen receptors. Am J Physiol Heart Circ Physiol 278: H2008-2019.
29. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, et al. (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314: 1780-1783.
30. Sacerdoti-Sierra N, Jaffe CL (1997) Release of ecto-protein kinases by the protozoan parasite Leishmania major. J Biol Chem 272: 30760-30765.
31. Knockaert M, Gray N, Damiens E, Chang YT, Grellier P, et al. (2000) Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem Biol 7: 411-422.
32. Lester DS, Hermoso T, Jaffe CL (1990) Extracellular phosphorylation in the parasite, Leishmania major. Biochim Biophys Acta 1052: 293-298.
33. Hermoso T, Jaffe CL (1993) Phosphorylation of proteins in virulent promastigotes from Leishmania major. Biol Res 26: 267-271.
34. Hermoso T, Perez JL, Cornivelli L, Hernandez AG (1994) Extracellular phosphorylation in Leishmania major and Leishmania mexicana during heat shock transformation. Acta Trop 56: 1-6.
35. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
36. Lam JS, Wang L, Lin L, Chan SO (2008) Role of protein kinase C in selective inhibition of mouse retinal neurites during contacts with chondroitin sulfates. Neurosci Lett 434: 150-154.
37. Gallagher SR (2007) One-dimensional SDS gel electrophoresis of proteins. Curr Protoc Cell Biol Chapter 6: -Unit 6 1.
38. Alexander J, Satoskar AR, Russell DG (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112 Pt 18: 2993-3002.
39. Vannier-Santos MA, Martiny A, de Souza W (2002) Cell biology of Leishmania spp.: invading and evading. Curr Pharm Des 8: 297-318.
40. Epand RM, Lester DS (1990) The role of membrane biophysical properties in the regulation of protein kinase C activity. Trends Pharmacol Sci 11: 317-320.
41. Birchall AM, Bishop J, Bradshaw D, Cline A, Coffey J, et al. (1994) Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J Pharmacol Exp Ther 268: 922-929.
42. Merritt JE, Sullivan JA, Drew L, Khan A, Wilson K, et al. (1999) The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells. Cancer Chemother Pharmacol 43: 371-378.
43. Keith K, Hide G, Tait A (1990) Characterisation of protein kinase C like activities in Trypanosoma brucei. Mol Biochem Parasitol 43: 107-116.
44. Gomez ML, Ochatt CM, Kazanietz MG, Torres HN, Tellez-Inon MT (1999) Biochemical and immunological studies of protein kinase C from Trypanosoma cruzi. Int J Parasitol 29: 981-989.
45. Makioka A, Kumagai M, Ohtomo H, Kobayashi S, Takeuchi T (2000) Entamoeba invadens: protein kinase C inhibitors block the growth and encystation. Exp Parasitol 95: 288-290.
46. Robert-Gangneux F, Creuzet C, Dupouy-Camet J, Roisin MP (2000) Involvement of the mitogen-activated protein (MAP) kinase signalling pathway in host cell invasion by Toxoplasma gondii. Parasite 7: 95-101.
47. Doyle PS, Engel JC, Pimenta PF, da Silva PP, Dwyer DM (1991) Leishmania donovani: long-term culture of axenic amastigotes at 37 degrees C. Exp Parasitol 73: 326-334.
48. Banerjee C, Sarkar D (1992) Isolation and characterization of a cyclic nucleotide-independent protein kinase from Leishmania donovani. Mol Biochem Parasitol 52: 195-205.
49. Besteiro S, Williams RA, Morrison LS, Coombs GH, Mottram JC (2006) Endosome sorting and autophagy are essential for differentiation and virulence of Leishmania major. J Biol Chem 281: 11384-11396.
50. Wiese M, Kuhn D, Grunfelder CG (2003) Protein kinase involved in flagellar-length control. Eukaryot Cell 2: 769-777.
51. Kuhn D, Wiese M (2005) LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation. Mol Microbiol 56: 1169-1182.
52. Wiese M (2007) Leishmania MAP kinases-familiar proteins in an unusual context. Int J Parasitol 37: 1053-1062.
53. Erdmann M, Scholz A, Melzer IM, Schmetz C, Wiese M (2006) Interacting protein kinases involved in the regulation of flagellar length. Mol Biol Cell 17: 2035-2045.
54. Kultz D (1998) Phylogenetic and functional classification of mitogen- and stress-activated protein kinases. J Mol Evol 46: 571-588.
55. Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, et al. (2007) p38 mitogen-activated protein kinase pathway is involved in protein kinase C alpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 67: 4320-4327.
56. Herrling PL (2005) The drug discovery process. Prog Drug Res 62: 1-14.